N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide

C20H25N3O3 — CID 88916148

IUPACN-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide
SMILESC=C1CCC(NC(=O)CCc2ccccc2)C(=O)N2[C@H](C=O)CCCN12
InChIInChI=1S/C20H25N3O3/c1-15-9-11-18(20(26)23-17(14-24)8-5-13-22(15)23)21-19(25)12-10-16-6-3-2-4-7-16/h2-4,6-7,14,17-18H,1,5,8-13H2,(H,21,25)/t17-,18?/m0/s1
InChIKeyMDVGEIOXRBKSFL-ZENAZSQFSA-N
MW355.44 g/mol
LogP1.82
Rot. Bonds5

About N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide

N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide (PubChem CID 88916148) has the molecular formula C20H25N3O3 and a molecular weight of 355.44 g/mol. Its IUPAC name is N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide.

Molecular Properties

Compound NameN-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide
PubChem CID88916148
Molecular FormulaC20H25N3O3
Molecular Weight355.44 g/mol
Exact Mass355.19
IUPAC NameN-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide
SMILESC=C1CCC(NC(=O)CCc2ccccc2)C(=O)N2[C@H](C=O)CCCN12
InChIInChI=1S/C20H25N3O3/c1-15-9-11-18(20(26)23-17(14-24)8-5-13-22(15)23)21-19(25)12-10-16-6-3-2-4-7-16/h2-4,6-7,14,17-18H,1,5,8-13H2,(H,21,25)/t17-,18?/m0/s1
InChIKeyMDVGEIOXRBKSFL-ZENAZSQFSA-N
XLogP1.82
TPSA69.72 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500355.44
LogP ≤ 51.82
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide?
The IUPAC name of N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide (CID 88916148) is N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide.
What is the SMILES notation for N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide?
The canonical SMILES for N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide is C=C1CCC(NC(=O)CCc2ccccc2)C(=O)N2[C@H](C=O)CCCN12.
What is the InChIKey of N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide?
The InChIKey is MDVGEIOXRBKSFL-ZENAZSQFSA-N. The full InChI is InChI=1S/C20H25N3O3/c1-15-9-11-18(20(26)23-17(14-24)8-5-13-22(15)23)21-19(25)12-10-16-6-3-2-4-7-16/h2-4,6-7,14,17-18H,1,5,8-13H2,(H,21,25)/t17-,18?/m0/s1.
What are the key properties of N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide?
N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide has a molecular weight of 355.44 g/mol, XLogP of 1.82, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4S)-4-formyl-10-methylidene-6-oxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepin-7-yl]-3-phenylpropanamide is sourced from PubChem (CID 88916148), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).